Table 2.
Description of the most utilized antibiotics (drug utilization 90%) in inpatients and outpatients.
| antibiotic group | DDDs/100 patient-days (IP) | DDDs/100 admissions (IP) | DDDs/100 outpatient visits | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Med | O&G | Surg | Total | Med | O&G | Surg | Total | Med | O&G | Surg | |
| Aminopenicillins | 171.73 | 11.07 | 313.43 | 60.32 | 536.02 | 47.13 | 786.33 | 235.79 | 18.03 | 18.05 | 8.6 | 37.75 |
| Aminopenicillin & enzyme inhibitor | 19.95 | 39.6 | 3.55 | 31.82 | 62.27 | 168.62 | 8.91 | 124.36 | 20.23 | 25.27 | 5.17 | 37.41 |
| 3rd generation cephalosporins | 76.94 | 47.15 | 117.54 | 29.28 | 240.16 | 200.78 | 294.89 | 114.44 | 17.43 | 20.45 | 15.23 | 13.4 |
| Lincosamides | 1.41 | 2.17 | 0.23 | 2.91 | 4.41 | 9.23 | 0.57 | 11.38 | 0.05 | 0.03 | 0.03 | 0.13 |
| Tetracyclines | 17.06 | 59.75 | 2.84 | 2.48 | 53.26 | 254.46 | 7.12 | 9.7 | 47.28 | 67.1 | 29.14 | 28.7 |
| Imidazoles | 23.61 | 22.74 | 13.94 | 42.67 | 73.68 | 96.86 | 34.98 | 166.78 | 16.84 | 15.14 | 15.79 | 23.87 |
| Macrolides | 4.99 | 7.54 | 5.43 | 1.7 | 15.59 | 32.13 | 13.62 | 6.66 | 7.36 | 9 | 7.06 | 3.32 |
| Quinolones | 11.57 | 30.42 | 1.66 | 12 | 36.13 | 129.54 | 4.15 | 46.91 | 25.24 | 31.26 | 19.57 | 19.92 |
| Co-trimoxazole | 2.04 | 2.71 | 0.56 | 4.18 | 6.36 | 11.53 | 1.4 | 16.33 | 1.01 | 1.06 | 0.55 | 1.84 |
| Aminoglycosides | 9.44 | 9.55 | 4.09 | 19.41 | 29.46 | 40.67 | 10.26 | 75.89 | 0.3 | 0.31 | 0.09 | 0.69 |
DDDs, defined daily doses; IP, inpatients; Med, Medicine; O&G, Obstetrics and Gynaecology; Surg, Surgery.